Trial NCT02723838

View at ClinicalTrials.gov 
Org. Study IDs: REO 023

Last trial update was posted on 2017-03-07

MeSH Interventions

Gemcitabine

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Muscle-invasive Transitional Cell Carcinoma of the Bladder

Stopping Reasons

Company has reprioritized clinical plans to focus on later-stage studies.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID